Evidence map›Paper›PMID 41166112›Full record

ArticleJournal of medical microbiology2025

A viable but nonculturable state of

Iris Schuiermanni, Eva Terschlüsen, Henrieke de Man, Jelmer Raaijmakers, Sandra Salillas, Jodie A Schildkraut, Jakko van Ingen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Macrolide-resistantJournal of clinical tuberculosis and other mycobacterial diseases · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Iris SchuiermanniDepartment of Medical Microbiology, Radboudumc Community for Infectious Diseases, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, the Netherlands.
Eva TerschlüsenDepartment of Medical Microbiology, Radboudumc Community for Infectious Diseases, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, the Netherlands.
Henrieke de ManDepartment of Medical Microbiology, Gelderse Vallei Hospital, Willy Brandtlaan 10, 6710 HN, Ede, the Netherlands.
Jelmer RaaijmakersDepartment of Medical Microbiology, Radboudumc Community for Infectious Diseases, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, the Netherlands.
Sandra SalillasDepartment of Medical Microbiology, Radboudumc Community for Infectious Diseases, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, the Netherlands.
Jodie A SchildkrautDepartment of Medical Microbiology, Radboudumc Community for Infectious Diseases, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, the Netherlands.
Jakko van IngenDepartment of Medical Microbiology, Radboudumc Community for Infectious Diseases, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsClarithromycinMacrolidesMicrobial ViabilityMycobacterium avium ComplexMycobacterium avium-intracellulare InfectionDrug Resistance, BacterialHumansMicrobial Sensitivity TestsRecurrenceAnti-Bacterial AgentsClarithromycinMacrolidesazithromycinclarithromycinnontuberculous mycobacteriapersistertreatment failure

Identifiers

PMID41166112
PMCPMC12574950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.